Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Mar;51(3):449-54.
doi: 10.1002/mus.24495. Epub 2015 Jan 16.

Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria

Affiliations
Case Reports

Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluria

Sarah E Berini et al. Muscle Nerve. 2015 Mar.

Abstract

Introduction: A 24-year-old man with primary hyperoxaluria type 1 (PH1) presented with a rapidly progressive axonal and demyelinating sensorimotor polyradiculoneuropathy shortly after the onset of end-stage renal disease. His plasma oxalate level was markedly elevated at 107 µmol/L (normal<1.8 µmol/L).

Methods: A sural nerve biopsy was performed. Teased fiber and paraffin and epoxy sections were done and morphometric procedures were performed on this sample and on an archived sample from a 22-year-old man as an age- and gender-matched control. Embedded teased fiber electron microscopy was also performed.

Results: The biopsy revealed secondary demyelination and axonal degeneration. Under polarized light, multiple bright hexagonal, rectangular, and starburst inclusions, typical of calcium oxalate monohydrate crystals, were seen.

Conclusions: The proposed mechanisms of nerve damage include disruption of axonal transport due to crystal deposition, toxic effect of oxalate, or nerve ischemia related to vessel occlusion from oxalate crystal deposition.

Keywords: crystalline neuropathy; nerve pathology; peripheral neuropathy; primary hyperoxaluria type 1; renal failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Teased fiber preparation of sural nerve: Calcium oxalate monohydrate crystals are noted by arrows on panel A under standard light and are clearly visible on panel B under polarized light. Note the associated perinodal demyelination.
Figure 2
Figure 2
Methyl violet preparation: Two starburst crystals are noted adjacent to an epineurial blood vessel. Panels B and D are under polarized light.
Figure 3
Figure 3
Epoxy sections stained with methylene blue reveal multifocal fiber loss, prominent axonal degeneration (arrow), and calcium oxalate crystals within nerve fibers (box). Panel B is under polarized light.
Figure 4
Figure 4
Electron microscopy along the course of an individual plastic embedded teased nerve fiber reveals a calcium oxalate monohydrate crystal within nerve myelin just outside of the axolemma. In box A the arrow points to a crystal under polarized light on a single teased fiber. In box B the arrow points to that calcium oxalate crystal on an epoxy section stained with methylene blue.

References

    1. Bilbao JM, Berry H, Merotta J, Ross RC. Peripheral neuropathy in oxalosis. A case report with electron microscopic observations. Le Journal Canadien Des Sciences Neurologiques. 1976;3(1):63–67. - PubMed
    1. Daudon M, Jungers P, Bazin D. Peculiar morphology of stones in primary hyperoxaluria. New England Journal of Medicine. 2008;359(1):100–102. - PubMed
    1. Moorhead PJ, Cooper DJ, Timperley WR. Progressive peripheral neuropathy in patient with primary hyperoxaluria. British Medical Journal. 1975;2:312–313. - PMC - PubMed
    1. Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int. 2009 Jun;75(12):1264–1271. - PMC - PubMed
    1. Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int. 2006 Nov;70(9):1642–1648. - PubMed

Publication types

Substances

Supplementary concepts

LinkOut - more resources